Date published: 2026-5-5

1-800-457-3801

SCBT Portrait Logo
Seach Input

MLTK Inhibitors

MLTK inhibitors belong to a specific chemical class of compounds that are designed to target and modulate the activity of the MLTK enzyme. MLTK, which stands for "Mammalian Lysine 2,3-aminomutase and transaldolase enzyme K" is an essential enzyme involved in specific biochemical pathways. The inhibitors are carefully designed molecules that are capable of binding to the active site of MLTK, thereby impeding its enzymatic activity. By doing so, MLTK inhibitors can regulate the biochemical processes in which MLTK plays a pivotal role. These inhibitors are usually small organic molecules with precise structural features that ensure their selective and potent interaction with MLTK. Researchers and scientists are actively investigating the potential applications of MLTK inhibitors in various fields due to the significance of the enzyme in cellular processes. The development and characterization of these inhibitors contribute significantly to our understanding of the intricate molecular mechanisms associated with MLTK, offering valuable insights for future scientific studies and possible applications in relevant domains.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 364947

396129-53-6sc-203122
sc-203122A
5 mg
10 mg
$107.00
$156.00
4
(1)

LY 364947 (CAS 396129-53-6) is a chemical compound known as an inhibitor of MLTK, effectively obstructing the activity of the MLTK enzyme. Its role as an MLTK inhibitor can modulate specific cellular processes and signaling pathways, making it valuable for various research purposes.

Trametinib

871700-17-3sc-364639
sc-364639A
sc-364639B
5 mg
10 mg
1 g
$114.00
$166.00
$947.00
19
(1)

Another MEK1/2 inhibitor used for metastatic melanoma with specific BRAF mutations, as well as non-small cell lung cancer.

MEK 162

606143-89-9sc-488879
10 mg
$306.00
(0)

Another MEK inhibitor used in combination with encorafenib for certain types of melanoma.

Selumetinib

606143-52-6sc-364613
sc-364613A
sc-364613B
sc-364613C
sc-364613D
5 mg
10 mg
100 mg
500 mg
1 g
$29.00
$82.00
$420.00
$1897.00
$3021.00
5
(1)

A MEK inhibitor being investigated for various cancers, including neurofibromatosis type 1-related tumors and uveal melanoma.

SCH772984

942183-80-4sc-473205
5 mg
$370.00
5
(0)

An ERK1/2 inhibitor studied for its potential in impacting RAS/RAF-mutant cancers.

Ulixertinib

869886-67-9sc-507296
10 mg
$176.00
(0)

A potent and selective ERK1/2 inhibitor undergoing research and early-phase evaluations.

VX-11e

896720-20-0sc-507301
10 mg
$180.00
(0)

A dual MEK and MLK inhibitor with potential antitumor activity.

LY3214996

1951483-29-6sc-507299
5 mg
$265.00
(0)

An investigational pan-RAF kinase inhibitor, which affects both wild-type and mutant RAF proteins.